Insider Transactions in Q3 2023 at Mana Capital Acquisition Corp. (MAAQR)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2023
|
Stanley K. Lau Director |
BUY
Exercise of conversion of derivative security
|
Direct |
42,647
+22.44%
|
$0
$0.34 P/Share
|
|
Sep 30
2023
|
Oded Levy Director |
BUY
Exercise of conversion of derivative security
|
Direct |
36,765
+38.89%
|
$0
$0.34 P/Share
|
|
Sep 30
2023
|
James Intrater Director |
BUY
Exercise of conversion of derivative security
|
Direct |
36,765
+38.89%
|
$0
$0.34 P/Share
|
|
Sep 30
2023
|
Brandon Sim Director |
BUY
Exercise of conversion of derivative security
|
Direct |
36,765
+38.89%
|
$0
$0.34 P/Share
|
|
Aug 31
2023
|
Stanley K. Lau Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,637
+9.49%
|
$0
$0.55 P/Share
|
|
Aug 31
2023
|
Meeshanthini Dogan Chief Technology Officer |
BUY
Open market or private purchase
|
Indirect |
16,481
+11.38%
|
$0
$0.55 P/Share
|
|
Aug 31
2023
|
Timur Dogan Chief Technology Officer |
BUY
Open market or private purchase
|
Direct |
16,481
+11.38%
|
$0
$0.55 P/Share
|
|
Aug 28
2023
|
Robert Philibert Chief Medical Officer |
BUY
Open market or private purchase
|
Indirect |
18,000
+0.54%
|
$0
$0.59 P/Share
|
|
Aug 25
2023
|
Meeshanthini Dogan Chief Technology Officer |
BUY
Open market or private purchase
|
Indirect |
1,770
+1.56%
|
$0
$0.56 P/Share
|
|
Aug 25
2023
|
Timur Dogan Chief Technology Officer |
BUY
Open market or private purchase
|
Direct |
1,770
+1.56%
|
$0
$0.56 P/Share
|
|
Aug 24
2023
|
Robert Philibert Chief Medical Officer |
BUY
Open market or private purchase
|
Indirect |
16,000
+0.97%
|
$0
$0.6 P/Share
|
|
Jul 31
2023
|
Stanley K. Lau Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,653
+5.05%
|
$1,653
$1.21 P/Share
|
|
Jul 01
2023
|
Stanley K. Lau Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,403
+22.22%
|
$8,403
$1.19 P/Share
|